Epinephrine
Also known as: Adrenalin, Auvi-Q, Epipen, Neffy.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 0.1 MG | Auto-injector | $297.64 / unit | $595.29 / 2 EA box | Brand |
| 0.15 MG | Auto-injector | $128.91 / unit | $257.81 / 2 EA box | Generic |
| 0.3 MG | Auto-injector | $134.91 / unit | $269.82 / 2 EA box | Generic |
| 1 MG/ML | Vial | $7.80 / mL† | — | Brand |
| 1 MG/10 ML | (unspecified) | $1.20 / mL | — | Generic |
| 1 MG/0.1 ML | Spray | $360.29 / unit | $720.57 / 2 EA box | Brand |
| 2 MG/0.1 ML | Spray | $359.83 / unit | $719.65 / 2 EA box | Brand |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet). Box prices are per full package where the size is known.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $268,514,279 gross for Epinephrine across 1,042,321 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$119,280,229 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS